CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF
    2.
    发明公开
    CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF 审中-公开
    碳氢化合物在DALEN SALZE

    公开(公告)号:EP1380562A1

    公开(公告)日:2004-01-14

    申请号:EP02720489.0

    申请日:2002-04-18

    申请人: Eisai Co., Ltd.

    IPC分类号: C07C59/64

    摘要: The present invention provides a novel carboxylic acid compound, a salt thereof or a hydrate of them useful as an insulin sensitizer, and a medicament comprising the compound as an active ingredient. That is, the present invention provides a carboxylic acid compound represented by the following formula, a salt thereof, an ester thereof or a hydrate of them.
    Wherein R 1 represents a hydrogen atom, hydroxyl group, halogen, carboxyl group, or a C 1-6 alkyl group etc., each of which may have one or more substituents; L represents a single bond, or a C 1-6 alkylene group, a C 2-6 alkenylene group or a C 2-6 alkynylene group, each of which may have one or more substituents; M represents a single bond, or a C 1-6 alkylene group, a C 2-6 alkenylene group or a C 2-6 alkynylene group, each of which may have one or more substituents; T represents a single bond, or a C 1-3 alkylene group, a C 2-3 alkenylene group or a C 2-3 alkynylene group, each of which may have one or more substituents; W represents a carboxyl group;
    - - -
    represents a single bond etc. ; X represents a single bond, oxygen atom, a group represented by -NR X1 CQ 1 O- (wherein Q 1 represents an oxygen atom or sulfur atom; and R X1 represents a hydrogen atom, formyl group, or a C 1-6 alkyl group etc., each of which may have one or more substituents), -OCQ 1 NR X1 - (wherein Q 1 and R X1 are as defined above), -CQ 1 NR x1 O- (wherein Q 1 and R X1 are as def ined above), ONR X1 CQ 1 - (wherein Q 1 and R X1 are as defined above), - Q 2 SO 2 - (wherein Q 2 is an oxygen atom or -NR X10 - (wherein R X10 represents a hydrogen atom, formyl group, or a C 1-6 alkyl group etc., each of which may have one or more substituents)) or -SO 2 Q 2 - (wherein Q 2 is as defined above),
    (wherein, provided that R X2 and R X3 , and/or R X4 and R X5 may together form a ring, Q 3 and Q 4 are the same as or different from each other and each represents an oxygen atom, (O)S(O) or NR X10 (wherein NR X10 is as defined above)); Y represents a 5- to 14-membered aromatic group etc., which may have one or more substituents and one or more hetero atoms; and the ring Z represents a 5-to 14-membered aromatic group which may have 0 to 4 substituents and one or more hetero atoms, and wherein part of the ring may be saturated.

    摘要翻译: 本发明提供了可用作胰岛素敏化剂的新型羧酸化合物,其盐或其水合物,以及包含该化合物作为活性成分的药物。 也就是说,本发明提供由下式表示的羧酸化合物,其盐,其酯或它们的水合物。 其中R 1表示氢原子,羟基,卤素,羧基或C 1-6烷基等,其各自可具有一个或多个取代基; L表示可以具有一个或多个取代基的单键或C 1-6亚烷基,C 2-6亚烯基或C 2-6亚炔基, M表示单键或C 1-6亚烷基,C 2-6亚烯基或C 2-6亚炔基,其各自可具有一个或多个取代基; T表示可以具有一个或多个取代基的单键或C 1-3亚烷基,C 2-3亚烯基或C 2-3亚炔基, W表示羧基; - - - 代表单一债券等; X表示单键,氧原子,-NR X X1表示的基团,其中Q 1表示氧原子或硫原子,R X1表示氢原子,甲酰基 ,或C 1-6烷基等,其各自可以具有一个或多个取代基),-OCQ 1 NR X1 - (其中Q 1和R X1如上所定义), - CQ <1> NR O-(其中Q 1和R X 1如上所定义),ONR X1和Q 1 - (其中Q 1和R X1均为 (其中Q 2是氧原子或-NR X 10 - (其中R X 10表示氢原子,甲酰基或C 1-6烷基等) ,其中每个可以具有一个或多个取代基))或-SO 2 Q 2 - (其中Q 2如上所定义),(其中,条件是R X2和R X3,和/或 R X和R X可以一起形成环,Q 3和Q 4彼此相同或不同,并且各自表示氧原子,(O)S(O)或NR X10>(其中NR X10如上所定义)); Y表示可以具有一个或多个取代基和一个或多个杂原子的5至14元芳族基团等; 并且环Z表示可以具有0至4个取代基和一个或多个杂原子的5至14元芳族基团,并且其中部分环可以是饱和的。